Skip to content

Clinical trials

Inflammatory Breast Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Breast Neoplasms Country / region: United States Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20022
20035
20041
20055
20066
20075
20081
20093
20103
20122
20131
20142
20153
20163
20175
20183
20193
20213
20223
20232
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated14
Active, not recruiting11
Recruiting6
Unknown status6
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center17
National Cancer Institute (NCI)10
City of Hope Medical Center6
Dana-Farber Cancer Institute4
Duke University2
GlaxoSmithKline2
H. Lee Moffitt Cancer Center and Research Institute2
Memorial Sloan Kettering Cancer Center2
Northwestern University2
SWOG Cancer Research Network2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Breast Neoplasms78
Breast Neoplasms64
Triple Negative Breast Neoplasms13
Breast Neoplasms, Male11
Bile Duct Neoplasms4
Carcinoma, Ductal, Breast4
Carcinoma, Hepatocellular4
Carcinoma, Lobular4
Carcinoma, Non-Small-Cell Lung4
Pancreatic Neoplasms4

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.